XERI (Xeriant) Research & Development: $0.11 Mil (TTM As of Mar. 2026)


What is Xeriant Research & Development?

Xeriant XERI +1.78% Research & Development is $0.11 Mil as of Mar. 2026. The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Xeriant's Research & Development for the three months ended in Mar. 2026 was $0.03 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0.11 Mil.

Xeriant  (OTCPK:XERI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Xeriant Research & Development Related Terms

Xeriant Research & Development Historical Data

* Premium members only.

The historical data trend for Xeriant's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xeriant Research & Development Chart

Xeriant Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.37 5.27 0.00 0.20 0.07

Xeriant Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.01 0.05 0.02 0.03

Xeriant Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.11 Mil mean?
Xeriant (XERI) has a Research & Development of $0.11 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Xeriant and its competitors.
Is Xeriant's Research & Development too high?
Xeriant's current Research & Development is $0.11 Mil.
How does Xeriant's Research & Development compare to AIRI and KITT?
Xeriant's Research & Development of $0.11 Mil can be compared against companies in the Aerospace & Defense industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Aerospace & Defense company?
A good Research & Development depends on the Aerospace & Defense industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Xeriant and its competitors. Xeriant's current Research & Development is $0.11 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xeriant stock overvalued right now?
Xeriant (XERI) has a current Research & Development of $0.11 Mil. The current Research & Development is $0.11 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Xeriant (XERI), the current Research & Development is $0.11 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Xeriant Business Description

Address 3651 FAU Boulevard, Suite 400, Boca Raton, FL, USA, 33431
Xeriant Inc is a holding and operating company focused on acquiring, developing, and commercializing revolutionary, eco-friendly technologies with applications in aerospace, including aircraft concepts targeting emerging opportunities within the aviation industry. In 2019, Xeriant acquired a scalable, multi-purpose VTOL aerial platform called Halo, which is protected under a broad utility patent. Xeriant is located at the Research Park at Florida Atlantic University in Boca Raton, Florida, adjacent to the Boca Raton Airport.